KI
AMED

Kalmar Investments’s Amedisys AMED Stock Holding History

Kalmar Investments’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		$4.36M Sell
85,325
-126,480
-60% -$6.03M 0.98% 57
2016
Q4 		$9.03M Sell
211,805
-56,560
-21% -$2.41M 0.46% 83
2016
Q3 		$12.7M Buy
+268,365
New +$13.4M 0.58% 75

Other funds holding AMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return

Kalmar Investments's AMED Position: Q1 2017 in Review

Kalmar Investments reduced its Amedisys (AMED) stake by 60% in Q1 2017, selling an estimated $6.03M and leaving 85,325 shares worth $4.36M. The position accounts for 0.98% of the portfolio, ranked #57.

Kalmar Investments first reported a position in AMED in Q3 2016 and has held it in 3 quarters since. The position peaked at $12.7M in Q3 2016. 152 funds tracked by Wall St. Rank hold AMED as of Q1 2017.

  • Kalmar Investments held 85,325 shares of Amedisys worth $4.36M as of Q1 2017.
  • Kalmar Investments sold 126,480 Amedisys shares in Q1 2017, an estimated $6.03M.
  • Amedisys made up 0.98% of Kalmar Investments's portfolio in Q1 2017, its #57 holding.
  • Kalmar Investments first reported a position in Amedisys in Q3 2016 and has held it in 3 quarters since.
  • Kalmar Investments's Amedisys position peaked at $12.7M in Q3 2016.
  • 152 funds tracked by Wall St. Rank held Amedisys as of Q1 2017.

Based on Kalmar Investments's 13F filing for Q1 2017, filed 26 Apr 2017.